Loading...
RICH logo

Laboratorios Richmond S.A.C.I.F.BASE:RICH Stock Report

Market Cap AR$126.4b
Share Price
n/a
1Y44.9%
7D1.3%
1D0%
Portfolio Value
​
View

Laboratorios Richmond S.A.C.I.F.

BASE:RICH Stock Report

Market Cap: AR$126.4b

Laboratorios RichmondC.I.F (RICH) Stock Overview

Develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East. More details

RICH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health0/6
Dividends2/6

Rewards

Price-To-Earnings ratio (9.7x) is below the AR market (11.5x)

Risk Analysis

Interest payments are not well covered by earnings

Large one-off items impacting financial results

Dividend of 1.72% is not well covered by free cash flows

Does not have a meaningful market cap (ARS126B)


RICH Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW442,510 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
442,510 investors already sharing narratives
View all narratives

Laboratorios Richmond S.A.C.I.F. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Laboratorios RichmondC.I.F
Historical stock prices
Current Share PriceAR$1,565.00
52 Week HighAR$2,300.00
52 Week LowAR$945.00
Beta-0.65
1 Month Change0.64%
3 Month Change0%
1 Year Change44.91%
3 Year Change189.55%
5 Year Change558.95%
Change since IPO4,129.73%

Recent News & Updates

Recent updates

Shareholder Returns

RICHAR PharmaceuticalsAR Market
7D1.3%-3.7%3.0%
1Y44.9%18.2%72.7%

Return vs Industry: RICH exceeded the AR Pharmaceuticals industry which returned 18.2% over the past year.

Return vs Market: RICH underperformed the AR Market which returned 72.7% over the past year.

Price Volatility

Is RICH's price volatile compared to industry and market?
RICH volatility
RICH Average Weekly Movement3.6%
Pharmaceuticals Industry Average Movement6.4%
Market Average Movement4.5%
10% most volatile stocks in AR Market6.4%
10% least volatile stocks in AR Market3.0%

Stable Share Price: RICH has not had significant price volatility in the past 3 months compared to the AR market.

Volatility Over Time: RICH's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1959n/aJuan Manuel Artolawww.richmondlab.com

Laboratorios Richmond S.A.C.I.F., together with its subsidiaries, develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East. It offers antiretroviral drugs for the treatment of human immunodeficiency virus; oncology and oncohematology drugs; cardiometabolism drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs, such as analgesics, antipsychotics, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company was incorporated in 1959 and is headquartered in Buenos Aires, Argentina.

Laboratorios Richmond S.A.C.I.F. Fundamentals Summary

How do Laboratorios RichmondC.I.F's earnings and revenue compare to its market cap?
RICH fundamental statistics
Market capAR$126.38b
Earnings (TTM)AR$13.04b
Revenue (TTM)AR$114.02b
9.7x
P/E Ratio
1.1x
P/S Ratio

Is RICH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RICH income statement (TTM)
RevenueAR$114.02b
Cost of RevenueAR$43.34b
Gross ProfitAR$70.68b
Other ExpensesAR$57.63b
EarningsAR$13.04b

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)161.53
Gross Margin61.99%
Net Profit Margin11.44%
Debt/Equity Ratio186.5%

How did RICH perform over the long term?

See historical performance and comparison

Dividends

1.7%
Current Dividend Yield
73%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/14 12:56
End of Day Share Price 2026/09/11 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Laboratorios Richmond S.A.C.I.F. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.